162 related articles for article (PubMed ID: 31384786)
1. Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study.
Dhiman P; Malik N; Khatkar A
BMC Chem; 2019 Dec; 13(1):38. PubMed ID: 31384786
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation.
Dhiman P; Malik N; Khatkar A
Curr Top Med Chem; 2018; 18(21):1857-1871. PubMed ID: 30430943
[TBL] [Abstract][Full Text] [Related]
3. In Silico Design, Synthesis of Hybrid Combinations: Quercetin Based MAO Inhibitors with Antioxidant Potential.
Dhiman P; Malik N; Khatkar A
Curr Top Med Chem; 2019; 19(2):156-170. PubMed ID: 30747068
[TBL] [Abstract][Full Text] [Related]
4. Hybrid caffeic acid derivatives as monoamine oxidases inhibitors: synthesis, radical scavenging activity, molecular docking studies and in silico ADMET analysis.
Dhiman P; Malik N; Khatkar A
Chem Cent J; 2018 Nov; 12(1):112. PubMed ID: 30413989
[TBL] [Abstract][Full Text] [Related]
5. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
6. Natural based piperine derivatives as potent monoamine oxidase inhibitors: an in silico ADMET analysis and molecular docking studies.
Dhiman P; Malik N; Khatkar A
BMC Chem; 2020 Dec; 14(1):12. PubMed ID: 32099971
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
Evranos-Aksoz B; Ucar G; Yelekci K
Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
[TBL] [Abstract][Full Text] [Related]
9. Filtration of Natural Derivatives as MAO Inhibitors by Virtual Screening: A Potential Lead for Neurodegenerative Disorders.
Malik N; Agnihotri S; Dhiman P
Cent Nerv Syst Agents Med Chem; 2024 Apr; ():. PubMed ID: 38584543
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
12. Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors.
Zarmouh NO; Messeha SS; Elshami FM; Soliman KF
European J Med Plants; 2016 May; 15(1):. PubMed ID: 27341283
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
14. 4-tert-Pentylphenoxyalkyl derivatives - Histamine H
Łażewska D; Olejarz-Maciej A; Kaleta M; Bajda M; Siwek A; Karcz T; Doroz-Płonka A; Cichoń U; Kuder K; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3596-3600. PubMed ID: 30404719
[TBL] [Abstract][Full Text] [Related]
15. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor.
Zarmouh NO; Messeha SS; Elshami FM; Soliman KF
Evid Based Complement Alternat Med; 2016; 2016():1423052. PubMed ID: 27118978
[TBL] [Abstract][Full Text] [Related]
18. Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A.
Baek SC; Park MH; Ryu HW; Lee JP; Kang MG; Park D; Park CM; Oh SR; Kim H
Bioorg Chem; 2019 Mar; 83():317-325. PubMed ID: 30396116
[TBL] [Abstract][Full Text] [Related]
19. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
20. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
